Benchmark raised the firm’s price target on Imax (IMAX) to $42 from $40 and keeps a Buy rating on the shares following the company’s investor day, which the firm says “underscored a powerful multi-year growth outlook,” supported by record box office momentum, rising market share, and “exceptional slate visibility” through 2028.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX: